CDSCO Cancels Import Licence of Mediderma Salipeel Products
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has cancelled the import registration of two cosmetic products of Satnam and Company after finding them in violation of the Cosmetics Rules, 2020, due to excessive concentration of salicylic acid beyond permissible limits.
According to the order issued by the Licensing Authority, a show cause notice had been served to the firm on April 7, 2025, for violation of Rule 39 of the Cosmetics Rules, 2020 and condition number 03 of the Registration Certificate. The notice was issued after scrutiny revealed that “the cosmetic product MEDIDERMA - SALIPEEL PLUS was found to contain salicylic acid in concentration at 25% as per the label claim and another product MEDIDERMA - SALIPEEL LIC was found to contain salicylic acid in concentration of 15% as per the list of ingredients.”
As per regulatory provisions, Salicylic acid (CAS No. 69-72-7) is allowed as a cosmetic ingredient only at restricted levels—“3% and 2% concentration for rinse-off hair products and other products respectively”—under Serial Number 98 of Annex B of IS 4707 (Part 4:2017).
The CDSCO order notes that the firm admitted in response to the show cause notice that these products are no longer part of its import activities in India.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.